- Home
- PTGX vs USA Comparison
PTGX vs USA Comparison
Compare PTGX & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- USA
- Stock Information
- Founded
- PTGX 2006
- USA 1986
- Country
- PTGX United States
- USA United States
- Employees
- PTGX N/A
- USA N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- USA Finance Companies
- Sector
- PTGX Health Care
- USA Finance
- Exchange
- PTGX Nasdaq
- USA Nasdaq
- Market Cap
- PTGX 3.7B
- USA 1.9B
- IPO Year
- PTGX 2016
- USA N/A
- Fundamental
- Price
- PTGX $58.86
- USA $6.53
- Analyst Decision
- PTGX Strong Buy
- USA
- Analyst Count
- PTGX 9
- USA 0
- Target Price
- PTGX $70.44
- USA N/A
- AVG Volume (30 Days)
- PTGX 900.7K
- USA 880.5K
- Earning Date
- PTGX 11-06-2025
- USA 01-01-0001
- Dividend Yield
- PTGX N/A
- USA 9.66%
- EPS Growth
- PTGX N/A
- USA N/A
- EPS
- PTGX 0.80
- USA N/A
- Revenue
- PTGX $209,180,000.00
- USA N/A
- Revenue This Year
- PTGX N/A
- USA N/A
- Revenue Next Year
- PTGX $185.11
- USA N/A
- P/E Ratio
- PTGX $73.16
- USA N/A
- Revenue Growth
- PTGX N/A
- USA N/A
- 52 Week Low
- PTGX $33.31
- USA $5.62
- 52 Week High
- PTGX $61.89
- USA $7.09
- Technical
- Relative Strength Index (RSI)
- PTGX 54.53
- USA 43.62
- Support Level
- PTGX $54.50
- USA $6.50
- Resistance Level
- PTGX $61.04
- USA $6.60
- Average True Range (ATR)
- PTGX 2.72
- USA 0.06
- MACD
- PTGX -0.07
- USA -0.00
- Stochastic Oscillator
- PTGX 59.00
- USA 28.13
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.